Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate

OBJECTIVE: To assess joint disease activity by ultrasound (US) in patients with rheumatoid arthritis (RA) initiating treatment with adalimumab (ADA) plus methotrexate (MTX). METHODS: Data for this post hoc analysis originated from the MUSICA trial (ClinicalTrials.gov identifier: NCT01185288), which...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaeley, Gurjit S., Nishio, Midori J., Goyal, Janak R., MacCarter, Daryl K., Wells, Alvin F., Chen, Su, Kupper, Hartmut, Kalabic, Jasmina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129587/
https://www.ncbi.nlm.nih.gov/pubmed/27214046
http://dx.doi.org/10.1002/art.39751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129587/
https://www.ncbi.nlm.nih.gov/pubmed/27214046
http://dx.doi.org/10.1002/art.39751

Ejemplares similares